Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 14, 2011; 17(26): 3145-3150
Published online Jul 14, 2011. doi: 10.3748/wjg.v17.i26.3145
Figure 1
Figure 1 Overall cumulative survival curve and cumulative survival curves in patients based on the number of lesions, tumor margin and percutaneous ethanol ablation dose. A: Overall cumulative survival curve in 63 hepatocellular carcinoma (HCC) patients receiving combined therapy of transcatheter arterial chemoembolization (TACE) and percutaneous ethanol ablation (PEA); B: Cumulative survival curves in patients based on the number of lesions; C: Cumulative survival curves in patients based on the tumor margin; D: Cumulative survival curves in patients based on PEA dose.